Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Immunocore Ltd.
Scientific Title
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma